Aspiration risk under anaesthesia: difference between revisions
Diff·revision 11 → 12·19:11, 30 Apr 2025
Difference between revision 11 and revision 12 of Aspiration risk under anaesthesia. 1 line changed; the page grew by 31 bytes.
| Revision 11 — 06:55, 5 Apr 2025 MolarMassMaeve (talk) add the discontinuation rate attributable to this effect 3,880 bytes ±0 | Revision 12 — 19:11, 30 Apr 2025 RetinopathyRex (talk) rm the reassurance sentence; the article should report, not reassure 3,911 bytes +31 | ||
|---|---|---|---|
| 44 | * [[Adverse effects of GLP-1 receptor agonists]] | 44 | * [[Adverse effects of GLP-1 receptor agonists]] |
| 45 | * [[GLP-1 receptor agonist]] | 45 | * [[GLP-1 receptor agonist]] |
| + | 46 | * [[Dose escalation schedule]] | |
| 46 | 47 | ||
| 47 | {{DEFAULTSORT:Aspiration risk under anaesthesia}} | 48 | {{DEFAULTSORT:Aspiration risk under anaesthesia}} |